Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 34246-54-3 | MDL No. : | MFCD09263482 |
Formula : | C9H10O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | LLYXUFQXCNIGDG-UHFFFAOYSA-N |
M.W : | 134.18 | Pubchem ID : | 118623 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.22 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 41.6 |
TPSA : | 17.07 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.54 cm/s |
Log Po/w (iLOGP) : | 1.84 |
Log Po/w (XLOGP3) : | 2.22 |
Log Po/w (WLOGP) : | 2.06 |
Log Po/w (MLOGP) : | 2.1 |
Log Po/w (SILICOS-IT) : | 2.79 |
Consensus Log Po/w : | 2.2 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 2.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.38 |
Solubility : | 0.556 mg/ml ; 0.00414 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.21 |
Solubility : | 0.821 mg/ml ; 0.00612 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.1 |
Solubility : | 0.106 mg/ml ; 0.000787 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.0 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
46% | With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; cesium acetate In tetrahydrofuran for 6 h; Reflux; Inert atmosphere | Triethylborane (1.00 M in THF, 2.00 mL, 2.00 mmol) was addedto a suspension of 3-bromobenzaldehyde (84) (0.370 g,2.00 mmol), Pd(dppf)Cl2 (14.6 mg, 20.0 lmol), and CsOAc(0.384 g, 2.00 mmol) in THF (3.0 mL) under Ar., and the mixturewas heated until reflux began this being maintained for 6 h. Aftercooling to room temperature, the mixture was diluted with Et2O,washed with saturated aqueous NaHCO3 and brine, dried (Na2SO4),filtered and concentrated in vacuo. The residue was purified by silicagel flash CC to afford 3-ethylbenzaldehyde (63) (0.123 g,0.920 mmol, 46percent) as a colorless oil; 1H-NMR (CDCl3, 400 MHz) d:1.28 (t, J = 7.2 Hz, 3H, –CH3), 2.74 (q, J = 7.2 Hz, 2H, –CH2–), 7.42–7.48, 7.69–7.72 (m, each 2H, Ar–H), 10.0 (s, 1H, –CHO); spectraldata were in agreement with those in the literature (Wang et al.,2009). |
[ 66-98-8 ]
[1,1'-Biphenyl]-4,4'-dicarbaldehyde
Similarity: 0.96
[ 400744-83-4 ]
3'-Methyl-[1,1'-biphenyl]-4-carbaldehyde
Similarity: 0.96
[ 3218-36-8 ]
[1,1'-Biphenyl]-4-carbaldehyde
Similarity: 0.96
[ 1203-68-5 ]
[1,1'-Biphenyl]-2-carbaldehyde
Similarity: 0.96
[ 112892-88-3 ]
Bicyclo[4.2.0]octa-1,3,5-triene-3-carbaldehyde
Similarity: 0.96
[ 66-98-8 ]
[1,1'-Biphenyl]-4,4'-dicarbaldehyde
Similarity: 0.96
[ 400744-83-4 ]
3'-Methyl-[1,1'-biphenyl]-4-carbaldehyde
Similarity: 0.96
[ 3218-36-8 ]
[1,1'-Biphenyl]-4-carbaldehyde
Similarity: 0.96
[ 1203-68-5 ]
[1,1'-Biphenyl]-2-carbaldehyde
Similarity: 0.96
[ 112892-88-3 ]
Bicyclo[4.2.0]octa-1,3,5-triene-3-carbaldehyde
Similarity: 0.96